17β-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes

Molecular and Cellular Endocrinology

Volumn 279, Issue 1-2, 2007, Pages 16-25

  Kramer, P R ^a   Winger, V ^a   Kramer, S F ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Auto immune; CD16; Chromatin immunoprecipitation; Estradiol; Estrogen receptor; Expression; Luciferase; Promoter

Indexed keywords

CD16 ANTIGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; INTERLEUKIN 1BETA; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; ANTIESTROGEN; FC RECEPTOR; MESSENGER RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE RELEASE; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MONOCYTE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; WILD TYPE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TUMOR CELL LINE;

ANTIBODIES; BASE SEQUENCE; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; MOLECULAR SEQUENCE DATA; MONOCYTES; RECEPTORS, IGG; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35649000846     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.08.014     Document Type: Article

References (62)

1. Abrahams V.M., Cambridge G., Lydyard P.M., and Edwards J.C. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum. 43 (2000) 608-616
2. Ansar A.S., Penhale W.J., and Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 121 (1985) 531-551
3. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47 (1991) 22-31
4. Baeten D., Boots A.M., Steenbakkers P.G., Elewaut D., Bos E., Verheijden G.F., Berheijden G., Miltenburg A.M., Rijnders A.W., Veys E.M., and De K.F. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum. 43 (2000) 1233-1243
5. Beaven M.A., and Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol. Today 14 (1993) 222-226
6. Benhamou M., and Siraganian R.P. Protein-tyrosine phosphorylation: an essential component of Fc epsilon RI signaling. Immunol. Today 13 (1992) 195-197
7. Bhatia A., Blades S., Cambridge G., and Edwards J.C. Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments. Immunology 94 (1998) 56-63
8. Cutolo M., Sulli A., Seriolo B., Accardo S., and Masi A.T. Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 13 (1995) 217-226
9. Cutolo M., Villaggio B., Bisso A., Sulli A., Coviello D., and Dayer J.M. Presence of estrogen receptors in human myeloid monocytic cells (THP-1 cell line). Eur. Cytokine Netw. 12 (2001) 368-372
10. Dauvois S., White R., and Parker M.G. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci. 106 Pt 4 (1993) 1377-1388
11. Diaz D.S., Andren M., Martinsson P., Verbeek J.S., and Kleinau S. Expression of FcgammaRIII is required for development of collagen-induced arthritis. Eur. J. Immunol. 32 (2002) 2915-2922
12. Edwards J.C., and Cambridge G. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br. J. Rheumatol. 37 (1998) 126-130
13. Fawell S.E., White R., Hoare S., Sydenham M., Page M., and Parker M.G. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci U.S.A. 87 (1990) 6883-6887
14. Felten D.L. Epidemiology of the rheumatic diseases. In: McCarty D.J., and Koopman W.J. (Eds). Arthritis and allied conditions. A textbook of rheumatology (1993), Lea & Febiger, Philadelphia 17-48
15. Fenton M.J., Vermeulen M.W., Clark B.D., Webb A.C., and Auron P.E. Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 140 (1988) 2267-2273
16. Friedman D., Netti F., and Schreiber A.D. Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes. J. Clin. Invest. 75 (1985) 162-167
17. Geng Y., Tsai-Morris C.H., Zhang Y., and Dufau M.L. The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation. Biochem. Biophys. Res. Commun. 263 (1999) 366-371
18. Gomez F., Ruiz P., Bernal J.A., Escobar M., Garcia-Egido A., and Lopez-Saez J.J. Enhancement of splenic-macrophage fcgamma receptor expression by treatment with estrogens. Clin. Diagn. Lab. Immunol. 8 (2001) 806-810
19. Hench P.S. The ameliorating effect of pregnancy on chronic atrophi (infectious rheumatoid) arthritis, fibrosis and interim heat hydarthrosis. Mayo Clin. Proc. 13 (1938) 161-167
20. Henderson B., and Pettipher E.R. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin. Exp. Immunol. 75 (1989) 306-310
21. Holmdahl R., Jansson L., Meyerson B., and Klareskog L. Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response. Clin. Exp. Immunol. 70 (1987) 372-378
22. Kagari T., Tanaka D., Doi H., and Shimozato T. Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. J. Immunol. 170 (2003) 4318-4324
23. Kanda N., and Watanabe S. 17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J. Invest. Dermatol. 120 (2003) 1058-1066
24. Kawanaka N., Yamamura M., Aita T., Morita Y., Okamoto A., Kawashima M., Iwahashi M., Ueno A., Ohmoto Y., and Makino H. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46 (2002) 2578-2586
25. Klaassen R.J., Goldschmeding R., Tetteroo P.A., and Von dem Borne A.E. The Fc valency of an immune complex is the decisive factor for binding to low-affinity Fc gamma receptors. Eur. J. Immunol. 18 (1988) 1373-1377
26. Kleinau S., Martinsson P., and Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J. Exp. Med. 191 (2000) 1611-1616
27. Kramer P.R., Kramer S.F., and Guan G. 17 Beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 50 (2004) 1967-1975
28. Kramer P.R., and Wray S. 17-Beta-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis. J. Steroid Biochem. Mol. Biol. 81 (2002) 203-216
29. Krieg S.A., Krieg A.J., and Shapiro D.J. A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta-converting enzyme (caspase 1). Mol. Endocrinol. 15 (2001) 1971-1982
30. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
31. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19 (2005) 1951-1959
32. Ling S., Deng G., Ives H.E., Chatterjee K., Rubanyi G.M., Komesaroff P.A., and Sudhir K. Estrogen inhibits mechanical strain-induced mitogenesis in human vascular smooth muscle cells via down-regulation of Sp-1. Cardiovasc. Res. 50 (2001) 108-114
33. Masuda M., Morimoto T., De Haas M., Nishimura N., Nakamoto K., Okuda K., Komiyama Y., Ogawa R., and Takahashi H. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis. J. Rheumatol. 30 (2003) 1911-1917
34. Masuda M., Morimoto T., Kobatake S., Nishimura N., Nakamoto K., Dong X.H., Komiyama Y., Ogawa R., and Takahashi H. Measurement of soluble Fcgamma receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clin. Exp. Immunol. 132 (2003) 477-484
35. Mattsson R., Mattsson A., Holmdahl R., Whyte A., and Rook G.A. Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin. Exp. Immunol. 85 (1991) 41-47
36. McHugh N.J. Pregnancy loss, menopause, and the onset of rheumatoid arthritis. Ann. Rheum. Dis. 49 (1990) 817-818
37. Nardella F.A., Teller D.C., and Mannik M. Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J. Exp. Med. 154 (1981) 112-125
38. Nicholson R.I., Gee J.M., Manning D.L., Wakeling A.E., Montano M.M., and Katzenellenbogen B.S. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer. Ann. N. Y. Acad. Sci. 761 (1995) 148-163
39. Oliver J.M., Seagrave J., Stump R.F., Pfeiffer J.R., and Deanin G.G. Signal transduction and cellular response in RBL-2H3 mast cells. Prog. Allergy 42 (1988) 185-245
40. Osborne C.K., Wakeling A., and Nicholson R.I. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br. J. Cancer 90 Suppl. 1 (2004) S2-S6
41. Ostensen M., Aune B., and Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand. J. Rheumatol. 12 (1983) 69-72
42. Paolini R., Numerof R., and Kinet J.P. Kinase activation through the high-affinity receptor for immunoglobulin E. Immunomethods 4 (1994) 35-40
43. Persellin R.H. The effect of pregnancy on rheumatoid arthritis. Bull. Rheum. Dis. 27 (1976) 922-927
44. Pettipher E.R., Higgs G.A., and Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8749-8753
45. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
46. Polan M.L., Kuo A., Loukides J., and Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J. Clin. Endocrinol. Metab. 70 (1990) 480-484
47. Pope R.M., Teller D.C., and Mannik M. The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 517-521
48. Pottratz S.T., Bellido T., Mocharla H., Crabb D., and Manolagas S.C. 17 Beta-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93 (1994) 944-950
49. Sak K., and Everaus H. Nongenomic effects of 17beta-estradiol-diversity of membrane binding sites. J. Steroid Biochem. Mol. Biol. 88 (2004) 323-335
50. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322 (1986) 547-549
51. Srivastava S., Weitzmann M.N., Cenci S., Ross F.P., Adler S., and Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104 (1999) 503-513
52. Tremblay G.B., Tremblay A., Copeland N.G., Gilbert D.J., Jenkins N.A., Labrie F., and Giguere V. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol. Endocrinol. 11 (1997) 353-365
53. Vegeto E., Bonincontro C., Pollio G., Sala A., Viappiani S., Nardi F., Brusadelli A., Viviani B., Ciana P., and Maggi A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21 (2001) 1809-1818
54. Wakeling A.E. Use of pure antioestrogens to elucidate the mode of action of oestrogens. Biochem. Pharmacol. 49 (1995) 1545-1549
55. Wakeling A.E. Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocr. Relat. Cancer 7 (2000) 17-28
56. Wakeling A.E., and Bowler J. Steroidal pure antioestrogens. J. Endocrinol. 112 (1987) R7-R10
57. Wakeling A.E., and Bowler J. Novel antioestrogens without partial agonist activity. J. Steroid Biochem. 31 (1988) 645-653
58. Wardley A.M. Fulvestrant: a review of its development, pre-clinical and clinical data. Int. J. Clin. Pract. 56 (2002) 305-309
59. Welch G.R., Wong H.L., and Wahl S.M. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J. Immunol. 144 (1990) 3444-3448
60. Wirthmueller U., Kurosaki T., Murakami M.S., and Ravetch J.V. Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. J. Exp. Med. 175 (1992) 1381-1390
61. Wooley P.H., Whalen J.D., Chapman D.L., Berger A.E., Richard K.A., Aspar D.G., and Staite N.D. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 36 (1993) 1305-1314
62. Yano R., Yamamura M., Sunahori K., Takasugi K., Yamana J., Kawashima M., and Makino H. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients. Acta Med. Okayama 61 (2007) 89-98